查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1636664

2030 年麸胺基硫市场预测：按产品类型、形式、来源、应用和地区进行的全球分析

Glutathione Market Forecasts to 2030 - Global Analysis By Product Type, Form, Source, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球麸胺基硫市场预计为 4.0293 亿美元，预测期内复合年增长率为 10.2%，预计到 2030 年将达到 7.2164 亿美元。

麸胺基硫是一种强大的抗氧化剂，天然存在于细胞内，由三种胺基酸组成：麸酰胺酸、半胱胺酸和甘胺酸。它透过清除损害细胞并导致老化和慢性疾病的自由基和活性氧，在保护身体免受氧化压力发挥重要作用。麸胺基硫也是许多代谢功能所必需的，包括免疫系统功能、蛋白质修復和 DNA 合成。它还可以透过与毒素结合并将排放肝臟来帮助解毒危险物质。此外，麸胺基硫因其许多健康益处而被广泛用于补充剂和护肤品中，特别是它能够改善皮肤健康和促进肤色平衡。

根据《欧洲医学与健康科学杂誌》报导，麸胺基硫（GSH）是人体中最丰富的内源性合成自由基清除剂，缺乏会对健康产生负面影响。研究表明，慢性病患者的麸胺基硫水平降低高达 50%。

增加有关健康益处的知识

推动市场扩张的主要因素之一是人们越来越认识到麸胺基硫的健康益处。麸胺基硫是一种强大的抗氧化剂，有助于减少氧化压力併中和自由基，这两者都与衰老和糖尿病、癌症和心血管疾病等慢性疾病有关。它受到注重健康的消费者的青睐，因为它能够增强免疫系统并普遍改善细胞健康。此外，由于人们意识的增强，对麸胺基硫补充剂的需求也在增加，特别是对于那些希望改善整体健康状况和避免慢性疾病的人。

昂贵的製造和产品成本

生产成本高是限制麸胺基硫市场的主要因素之一。合成麸胺基硫，特别是还原态和生物可利用形式的谷胱甘肽，需要先进的技术和大量的研发投资。因此，麸胺基硫产品和补充剂比其他抗氧化剂更昂贵，因为生产成本增加转嫁给了客户。此外，由于其成本较高，一些富裕且注重健康的消费者往往不会购买麸胺基硫，这限制了其开拓市场的能力，特别是在开发中国家和其他价格敏感的地区。

对预防性医疗解决方案的需求不断增长

由于人们越来越重视预防保健，麸胺基硫市场前景广阔。随着人们对维持免疫和细胞健康的长期益处的了解不断增加，消费者开始寻求支持整体健康和慢性病预防的产品。麸胺基硫是一种主要的抗氧化剂，有助于排毒并减少氧化压力，使其成为促进预防的机能性食品和补充剂的重要成分。此外，这种趋势在老龄化社会中尤其明显，人们对促进长寿和健康老化的产品的需求不断增长。

市场竞争激烈

麸胺基硫市场与多酚、Coenzyme Q10、维生素 C 和维生素 E 等其他知名抗氧化剂展开激烈竞争。随着更新的抗氧化剂成分和化合物的推出，市场的竞争也可能变得更加激烈。此外，销售麸胺基硫的公司必须不断在行销和教育上投入资金，以使其产品与竞争对手区分开来并保护更高的价格，这给他们的财务和资源带来了压力。

COVID-19 的影响：

COVID-19 大流行对麸胺基硫市场产生了重大影响，提高了消费者对免疫健康的认识，并增加了对富含抗氧化剂的产品的需求。此外，麸胺基硫具有减少氧化压力和增强免疫力的潜力，使其在营养补充剂和机能性食品中越来越受欢迎。然而，疫情期间，生产和分销受到物流困难、供应链中断和原材料短缺的阻碍。儘管存在这些障碍，但由于消费者优先考虑自己的健康，这场流行病开闢了新的市场，并增加了对麸胺基硫药物和营养补充剂的需求。

还原型麸胺基硫(GSH) 产业预计将在预测期内成为最大的产业

预计麸胺基硫市场将由还原型麸胺基硫(GSH) 领域主导。其优越性的原因在于它被广泛应用于化妆品、药品、营养补充剂等各个领域。还原型麸胺基硫在免疫力增强补充剂和护肤配方中受到高度追捧，因为它具有强大的抗氧化品质、对抗氧化压力的能力以及众所周知的解毒过程参与作用。此外，其生物利​​用度和有效中和自由基的能力进一步巩固了其作为製造商和消费者首选的地位，推动了需求并保持了主导市场占有率。

在预测期内，静脉注射（IV）麸胺基硫领域预计复合年增长率最高

在麸胺基硫市场中，静脉注射 (IV)麸胺基硫细分市场预计将以最高的复合年增长率成长。静脉注射疗法的日益普及是这种快速增长的一个主要因素，它透过将营养物质直接输送到血液中并快速吸收来确保最大的有效性。由于麸胺基硫在皮肤美白、抗衰老和排毒方面具有显着的功效，诊所和健康中心经常使用静脉注射麸胺基硫。此外，医疗美容趋势的上升和慢性病盛行率的上升正在增加对静脉注射麸胺基硫治疗的需求。

比例最高的地区：

由于亚太地区对药品、化妆品和营养补充剂的需求量很大，预计该地区将占据麸胺基硫市场的最大份额。对健康和保健、抗衰老疗法和皮肤美白产品的日益关注，使得中国、日本和韩国等国家在生产和消费方面都处于领先地位。具有成本效益的生产方法和丰富的原材料供应进一步强化了该地区的优势。此外，该地区庞大的市场占有率也是都市化、可支配收入增加以及消费者对麸胺基硫益处了解不断增加的结果。

复合年增长率最高的地区：

北美地区的麸胺基硫市场预计将显着成长，复合年增长率最高。消费者对保健品的兴趣日益浓厚，特别是那些用于护肤、排毒和免疫系统支持的保健品，正在推动该地区对麸胺基硫的需求。市场成长是由完善的製药和营养保健品行业以及对抗氧化剂益处的广泛了解所推动的。此外，由于个人化营养和健康趋势的上升以及可支配收入的增加，北美麸胺基硫市场预计也将继续成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球麸胺基硫市场：依产品类型

  • 还原型麸胺基硫(GSH)
  • 氧化型麸胺基硫(GSSG)
  • 脂质体麸胺基硫
  • N-乙酰半胱胺酸（NAC）
  • S-麸胺基硫

第六章全球麸胺基硫市场：依形式

  • 口服胶囊或锭剂
  • 菱形
  • 液体
  • 静脉注射 (IV)麸胺基硫
  • 外用霜
  • 吸入

第七章全球麸胺基硫市场：依来源分类

  • 自然资源
    • 植物来源
    • 动物起源
  • 合成来源

第八章全球麸胺基硫市场：依应用分类

  • 营养补充品/营养补充品
  • 护肤
  • 呼吸系统健康
  • 静脉 (IV) 治疗
  • 运动营养
  • 慢性病管理
  • 化妆品
  • 食品/饮料
  • 药品
  • 其他用途

第九章全球麸胺基硫市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • Atrium Innovations
  • Kohjin Life Sciences Co., Ltd.
  • Bachem Inc
  • Mitsubishi Corporation Life Science Limited
  • Ajinomoto Group
  • Now Health Group, Inc
  • Meteoric Biopharmaceuticals
  • Kyowa Hakko Bio Co., Ltd.
  • Shenzhen GSH Bio-Technology Co., Ltd.
  • Parchem Fine & Specialty Chemicals
  • Jarrow Formulas, Inc.
  • Cayman Chemical Company
  • Shandong Jincheng Bio-pharmaceutical Co., Ltd.
  • Kyungdong Pharmaceutical Co., Ltd
  • Anhui GSH Bio-Technology
Product Code: SMRC28305

According to Stratistics MRC, the Global Glutathione Market is accounted for $402.93 million in 2024 and is expected to reach $721.64 million by 2030 growing at a CAGR of 10.2% during the forecast period. Glutathione is a powerful antioxidant naturally found in cells, composed of three amino acids which are glutamine, cysteine, and glycine. By scavenging free radicals and reactive oxygen species, which can harm cells and play a part in aging and chronic illnesses, it plays a vital part in shielding the body from oxidative stress. Glutathione is also necessary for a number of metabolic functions, such as immune system function, protein repair, and DNA synthesis. By attaching itself to toxins in the liver for elimination, it also helps detoxify dangerous substances. Moreover, glutathione is used extensively in supplements and skincare products because of its many health benefits, especially its ability to improve skin health and encourage a balanced complexion.

According to the European Journal of Medical and Health Sciences, glutathione (GSH) is the most abundant free radical scavenger synthesized endogenously in humans, and its deficiency can lead to adverse health consequences. Studies have shown that glutathione levels can decrease by up to 50% in individuals with chronic diseases.

Market Dynamics:

Driver:

Increasing knowledge of health advantages

One of the main factors propelling market expansion is growing awareness of glutathione's health advantages. Glutathione is a potent antioxidant that aids in the reduction of oxidative stress and the neutralization of free radicals, both of which are connected to aging and chronic illnesses like diabetes, cancer, and cardiovascular disorders. It is a well-liked option for consumers who are concerned about their health because of its ability to strengthen the immune system and improve cellular health in general. Additionally, the demand for glutathione supplements has increased as a result of this increased awareness, especially among people looking to enhance their general health and avoid chronic diseases.

Restraint:

Expensive production and product costs

The high cost of production is one of the main factors limiting the glutathione market. It takes sophisticated technologies and a large investment in research and development to synthesize glutathione, especially in its reduced and bioavailable forms. This results in increased production costs that are transferred to customers, making glutathione products and supplements more costly than other antioxidants. Furthermore, the high cost frequently prevents a certain group of wealthy or health-conscious consumers from purchasing it, which limits market expansion in areas where consumers are price sensitive, especially in developing nations.

Opportunity:

Growing need for healthcare preventative solutions

There are plenty of prospects for the glutathione market due to the increased emphasis on preventative healthcare. Growing knowledge of the long-term advantages of preserving immunological and cellular health has led consumers to look for products that support general wellness and the prevention of chronic illnesses. Since glutathione is a master antioxidant that helps with detoxification and lowers oxidative stress, it is a crucial component of functional foods and supplements meant to promote prevention. Moreover, this trend is especially noticeable in aging populations, where there is a greater need for goods that promote longevity and healthy aging.

Threat:

Vigorous competition in the market

The market for glutathione is fiercely competitive with other well-known antioxidants like polyphenols, coenzyme Q10, and vitamins C and E. The development of glutathione-based products is seriously threatened by these substitutes, which are frequently more widely known and less expensive. The market's introduction of more recent antioxidant ingredients and compounds could also make competition even fiercer. Furthermore, businesses that sell glutathione must constantly spend money on marketing and education to set their products apart from the competition and defend their higher prices, which can put a strain on finances and resources.

Covid-19 Impact:

The COVID-19 pandemic had a major impact on the glutathione market by raising consumer awareness of immune health and resulting in a greater demand for products high in antioxidants. Moreover, glutathione has become increasingly popular in dietary supplements and functional foods due to its potential to lower oxidative stress and boost immunity. But during the pandemic, production and distribution were hampered by logistical difficulties, supply chain interruptions, and shortages of raw materials. Notwithstanding these obstacles, the pandemic opened up new markets as consumers placed a higher priority on their health, which increased demand for glutathione-based pharmaceutical and nutraceutical products.

The Reduced Glutathione (GSH) segment is expected to be the largest during the forecast period

The glutathione market is expected to be dominated by the reduced glutathione (GSH) segment. Its extensive use in a variety of sectors, such as cosmetics, pharmaceuticals, and nutraceutical, is what accounts for its dominance. Reduced glutathione is highly sought after for immune-boosting supplements and skincare formulations because of its well-known strong antioxidant qualities, capacity to fight oxidative stress, and involvement in detoxification processes. Additionally, its bioavailability and ability to effectively neutralize free radicals have further cemented its status as a manufacturer's and consumer's preferred option, boosting demand and preserving its dominant market share.

The Intravenous (IV) Glutathione segment is expected to have the highest CAGR during the forecast period

In the glutathione market, the intravenous (IV) glutathione segment is anticipated to grow at the highest CAGR. The growing popularity of IV therapies, which ensure maximum efficacy through direct nutrient delivery into the bloodstream and rapid absorption, is the primary driver of this rapid growth. Due to its alleged advantages in skin lightening, anti-aging, and detoxification, IV glutathione is frequently utilized in clinics and wellness centers. Furthermore, the growing trend of medical aesthetics and the rising incidence of chronic diseases have increased demand for IV glutathione treatments.

Region with largest share:

Due to the high demand for pharmaceuticals, cosmetics, and nutraceutical in the Asia Pacific region, the region is expected to hold the largest share of the glutathione market. A growing emphasis on health and wellness, anti-aging remedies, and skin-whitening products has made countries like China, Japan, and South Korea leaders in both production and consumption. Its dominance is further enhanced by the region's cost-effective manufacturing methods and plentiful supply of raw materials. Moreover, the region's sizable market share is also a result of urbanization, growing disposable incomes, and growing consumer knowledge of glutathione's advantages.

Region with highest CAGR:

The glutathione market is expected to grow significantly in the North American region, with the highest CAGR. In this area, the growing interest of consumers in health supplements, especially those for skin care, detoxification, and immune system support, is driving the demand for glutathione. Market growth is facilitated by the existence of a firmly established pharmaceutical and nutraceutical sector as well as widespread knowledge of the advantages of antioxidants. Additionally, the glutathione market in North America is also anticipated to continue growing as a result of the growing trend of personalized nutrition and wellness as well as rising disposable incomes.

Key players in the market

Some of the key players in Glutathione market include Atrium Innovations, Kohjin Life Sciences Co., Ltd., Bachem Inc, Mitsubishi Corporation Life Science Limited, Ajinomoto Group, Now Health Group, Inc, Meteoric Biopharmaceuticals, Kyowa Hakko Bio Co., Ltd., Shenzhen GSH Bio-Technology Co., Ltd., Parchem Fine & Specialty Chemicals, Jarrow Formulas, Inc., Cayman Chemical Company, Shandong Jincheng Bio-pharmaceutical Co., Ltd., Kyungdong Pharmaceutical Co., Ltd and Anhui GSH Bio-Technology.

Key Developments:

In April 2024, Kyowa Hakko Bio, Co., Ltd. and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings Co., has opened its expanded citicoline manufacturing facility at its Kyowa Hakko Bio Yamaguchi Production Center in Hofu City, Yamaguchi Prefecture, Japan. With the expanded facility, the Kirin Group is planning to integrate citicoline into upcoming product development initiatives.

In November 2023, Ajinomoto Co., Inc. and Forge Biologics announced that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million1. This acquisition in the current biotech market is a remarkable testament to the technical advancements, world-class facility, and experienced capable leadership at Forge.

In March 2023, Bachem Group announced that it has signed a new framework agreement to provide large volumes of peptides following a joint development project. Manufacturing is to primarily occur at Bachem's new large-scale production facility currently under construction in Bubendorf.

Product Types Covered:

  • Reduced Glutathione (GSH)
  • Oxidized Glutathione (GSSG)
  • Liposomal Glutathione
  • N-acetylcysteine (NAC)
  • S-Acetyl Glutathione

Forms Covered:

  • Oral Capsules or Tablets
  • Lozenges
  • Liquids
  • Intravenous (IV) Glutathione
  • Topical Creams
  • Inhalation

Sources Covered:

  • Natural Sources
  • Synthetic Sources

Applications Covered:

  • Nutritional Supplements/ Nutraceutical Supplements
  • Skin Care
  • Respiratory Health
  • Intravenous (IV) Therapy
  • Sports Nutrition
  • Chronic Illness Management
  • Cosmetics
  • Food & Beverage
  • Pharmaceuticals
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Glutathione Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reduced Glutathione (GSH)
  • 5.3 Oxidized Glutathione (GSSG)
  • 5.4 Liposomal Glutathione
  • 5.5 N-acetylcysteine (NAC)
  • 5.6 S-Acetyl Glutathione

6 Global Glutathione Market, By Form

  • 6.1 Introduction
  • 6.2 Oral Capsules or Tablets
  • 6.3 Lozenges
  • 6.4 Liquids
  • 6.5 Intravenous (IV) Glutathione
  • 6.6 Topical Creams
  • 6.7 Inhalation

7 Global Glutathione Market, By Source

  • 7.1 Introduction
  • 7.2 Natural Sources
    • 7.2.1 Plant-based
    • 7.2.2 Animal-based
  • 7.3 Synthetic Sources

8 Global Glutathione Market, By Application

  • 8.1 Introduction
  • 8.2 Nutritional Supplements/ Nutraceutical Supplements
  • 8.3 Skin Care
  • 8.4 Respiratory Health
  • 8.5 Intravenous (IV) Therapy
  • 8.6 Sports Nutrition
  • 8.7 Chronic Illness Management
  • 8.8 Cosmetics
  • 8.9 Food & Beverage
  • 8.10 Pharmaceuticals
  • 8.11 Other Applications

9 Global Glutathione Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Atrium Innovations
  • 11.2 Kohjin Life Sciences Co., Ltd.
  • 11.3 Bachem Inc
  • 11.4 Mitsubishi Corporation Life Science Limited
  • 11.5 Ajinomoto Group
  • 11.6 Now Health Group, Inc
  • 11.7 Meteoric Biopharmaceuticals
  • 11.8 Kyowa Hakko Bio Co., Ltd.
  • 11.9 Shenzhen GSH Bio-Technology Co., Ltd.
  • 11.10 Parchem Fine & Specialty Chemicals
  • 11.11 Jarrow Formulas, Inc.
  • 11.12 Cayman Chemical Company
  • 11.13 Shandong Jincheng Bio-pharmaceutical Co., Ltd.
  • 11.14 Kyungdong Pharmaceutical Co., Ltd
  • 11.15 Anhui GSH Bio-Technology

List of Tables

  • Table 1 Global Glutathione Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Glutathione Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Glutathione Market Outlook, By Reduced Glutathione (GSH) (2022-2030) ($MN)
  • Table 4 Global Glutathione Market Outlook, By Oxidized Glutathione (GSSG) (2022-2030) ($MN)
  • Table 5 Global Glutathione Market Outlook, By Liposomal Glutathione (2022-2030) ($MN)
  • Table 6 Global Glutathione Market Outlook, By N-acetylcysteine (NAC) (2022-2030) ($MN)
  • Table 7 Global Glutathione Market Outlook, By S-Acetyl Glutathione (2022-2030) ($MN)
  • Table 8 Global Glutathione Market Outlook, By Form (2022-2030) ($MN)
  • Table 9 Global Glutathione Market Outlook, By Oral Capsules or Tablets (2022-2030) ($MN)
  • Table 10 Global Glutathione Market Outlook, By Lozenges (2022-2030) ($MN)
  • Table 11 Global Glutathione Market Outlook, By Liquids (2022-2030) ($MN)
  • Table 12 Global Glutathione Market Outlook, By Intravenous (IV) Glutathione (2022-2030) ($MN)
  • Table 13 Global Glutathione Market Outlook, By Topical Creams (2022-2030) ($MN)
  • Table 14 Global Glutathione Market Outlook, By Inhalation (2022-2030) ($MN)
  • Table 15 Global Glutathione Market Outlook, By Source (2022-2030) ($MN)
  • Table 16 Global Glutathione Market Outlook, By Natural Sources (2022-2030) ($MN)
  • Table 17 Global Glutathione Market Outlook, By Plant-based (2022-2030) ($MN)
  • Table 18 Global Glutathione Market Outlook, By Animal-based (2022-2030) ($MN)
  • Table 19 Global Glutathione Market Outlook, By Synthetic Sources (2022-2030) ($MN)
  • Table 20 Global Glutathione Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Glutathione Market Outlook, By Nutritional Supplements/ Nutraceutical Supplements (2022-2030) ($MN)
  • Table 22 Global Glutathione Market Outlook, By Skin Care (2022-2030) ($MN)
  • Table 23 Global Glutathione Market Outlook, By Respiratory Health (2022-2030) ($MN)
  • Table 24 Global Glutathione Market Outlook, By Intravenous (IV) Therapy (2022-2030) ($MN)
  • Table 25 Global Glutathione Market Outlook, By Sports Nutrition (2022-2030) ($MN)
  • Table 26 Global Glutathione Market Outlook, By Chronic Illness Management (2022-2030) ($MN)
  • Table 27 Global Glutathione Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 28 Global Glutathione Market Outlook, By Food & Beverage (2022-2030) ($MN)
  • Table 29 Global Glutathione Market Outlook, By Pharmaceuticals (2022-2030) ($MN)
  • Table 30 Global Glutathione Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.